Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.

By P. Aide, C. Dobaño, J. Sacarlal, J. Aponte, I. Mandomando, C. Guinovart, Q. Bassat, Montse Renom, L. Puyol, E. Macete and 11 more. 2011

43 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. F. Sallusto
2. A. Lanzavecchia
3. D. Veesler

In Molecular Biology

1. W. Sheffler
2. David Baker
3. Neil P. King
4. Lauren P. Carter
5. D. Veesler
6. F. Sallusto
7. Kelly K. Lee
8. Joost Snijder

In Public Health, Environmental and Occupational Health

1. D. Veesler

Citations in the corpus

• Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus (2019, positive): “Second, do anti-scaffold responses detract from or compete with the antigen-specific response? Our data are in accordance with previous studies (Aide et al., 2011; Kanekiyo et al., 2013) in that presentation of DS-Cav1 on the I53-50 nanoparticle induced higher antigen-specific responses despite the ”